UTRN and Duchenne muscular dystrophy: While the glycanated form does not seem to have a therapeutic value in DMD, the intraperitoneal injection of recombinant human nonglycanated biglycan upregulated utrophin, sarcoglycans, and nNOS, as well as improved the overall muscle health and function in mdx mice [196].